A R T I C L E S
Vogel et al.
have shed light on the signal transduction cascade involving
ras.4,9 One reaction partner of ras is Sos which is responsible
for its activation by catalyzing the release of guanosine
diphosphate (GDP) from ras and subsequently the binding of
guanosine triphosphate (GTP) resulting in its activation; ras then
further affects downstream effectors. Mutated forms of ras are
unable to hydrolyze GTP10 and therefore cannot return to the
deactivated state, which is believed to be connected to onco-
genesis. Sos is bound to stimulated receptor tyrosine kinases
via the protein Grb2 and thereby recruited from the cytoplasm
to the membrane. Binding of proteins to the cell membrane
increases their effective concentration by a factor of at least
1000.11 The reaction rate between two partners is strongly
increased by their localization at the membrane due to a higher
apparent affinity;12 if only one reaction partner is localized at
the membrane the rate is largely unaffected. When ras is also
bound to the membrane then a high reaction rate is followed
by transduction of the signal. By contrast, if the membrane
association of ras is disrupted then signal transduction is not
observed. Thus, manipulation of the membrane association of
ras plays an important regulatory role in controlling its function.
The second posttranslational modification is palmitoylation of
Cys181; the cellular location where this reaction takes place is
still under discussion. There are indications that the palmitoyl-
transferase is located at the cell membrane.20,22 A kinetic
trapping model postulates that the farnesylation is required to
induce transient binding events that establish contacts between
ras and the palmitoyltransferase.23 Both transferases are possible
targets for drug design, as ras is inactive when detached from
the cell membrane. Inhibitors for farnesyltransferase have been
found and tested with great success on mice and on human
tumor cells in cell cultures.24,25
Currently, there is strong interest in understanding the
mechanism of ras binding to the membrane via lipid modifica-
tions on account of their role in the development of cancer. In
a previous study we determined the localization of the peptide
within the lipid-water interface of the membrane.26 Here we
concentrate on molecular details of the lipid modifications
anchoring the ras heptapeptide to the phospholipid membrane.
2
Solid-state H NMR is a powerful tool to determine motional
parameters from line shape and relaxation rate analysis.27-31
2
Moreover, the H nucleus is well suited to study molecular
dynamics by NMR, as it has very favorable properties for
investigating molecular reorientations occurring over many
orders of magnitude in time.27-31 By application of a suitable
motional model, details of the geometry of the molecular motion
can be revealed from the 2H NMR data. In particular, compre-
hensive models have been worked out for the motions of the
acyl chains of the phospholipids in membranes.28,32-35 More
recently, 2H NMR relaxation in combination with order
parameter determination for the lipid chains has been success-
fully analyzed to determine elastic properties and deformations
of lipid membranes.36-39 We have applied this approach to a
membrane-associated lipid-modified ras peptide. The ras hep-
It has been shown that two posttranslational lipid modifica-
tions are necessary and sufficient to obtain the active form of
ras.13 In these posttranslational processing events, which target
ras from the cytosol to the plasma membrane, the cysteine of
the C-terminal -CAAX sequence (C is cysteine, A is an
aliphatic amino acid, X is serine or methionine) is first
farnesylated and then is recognized by a specific protease that
cleaves the -AAX residues. Finally the new farnesylated
cysteine at the C-terminus is converted to the methyl ester. In
the case of N- and H-ras but not K-ras, the peptide chain is
further modified by introduction of palmitic acid thioesters. 3-5
A single lipid modification apparently does not permanently
anchor ras to the cell membrane.14 Several biophysical studies
have investigated the distribution of lipid-modified peptides
between the membrane associated and the translocated cytosolic
state.11,15-19 It was found that the typical half-life for the
membrane-associated state is on the order of seconds for singly
lipidated peptides.15,18 Addition of a second lipid modification
increases the average half-life to the order of hours to days.16,20
These conclusions are supported by the observation that singly
lipid modified H-ras fails to activate mitogen-activated protein
kinase (MAPK)13 and that its activity is reduced by ∼98%.21
In N-ras initially Cys186 is farnesylated by a farnesyltransferase.
(22) Liu, L.; Dudler, T.; Gelb, M. H. J. Biol. Chem. 1996, 271, 23269-23276.
(23) Dunphy, J. T.; Linder, M. E. Biochim. Biophys. Acta 1998, 1436, 245-
261.
(24) Kohl, N. E.; Omer, C. A.; Conner, M. W.; Anthony, N. J.; Davide, J. P.;
deSolms, S. J.; Giuliani, E. A.; Gomez, R. P.; Graham, S. L.; Hamilton,
K. Nat. Med. 1995, 1, 792-797.
(25) Omer, C. A.; Kohl, N. E. Trends Pharmacol. Sci. 1997, 18, 437-444.
(26) Huster, D.; Vogel, A.; Katzka, C.; Scheidt, H. A.; Binder, H.; Dante, S.;
Gutberlet, T.; Zscho¨rnig, O.; Waldmann, H.; Arnold, K. J. Am. Chem. Soc.
2003, 125, 4070-4079.
(27) Davis, J. H. Biochim. Biophys. Acta 1983, 737, 117-171.
(28) Brown, M. F. J. Chem. Phys. 1982, 77, 1576-1799.
(29) (a) Vold, R. R.; Vold, R. L. In AdVances in Magnetic and Optical
Resonance; Warren, W. S., Ed.; Academic Press: San Diego, CA, 1991;
pp 85-171. (b) Vold, R. R. In Nuclear Magnetic Resonance Probes of
Molecular Dynamics; Tycko, R., Ed. Kluwer Academic Publishers:
Dodrecht, 1994; pp 27-112. (c) Wittebort, R. J.; Olejniczak, E. T.; Griffin,
R. G. J. Phys. Chem. 1987, 86, 5411-5420.
(9) Hinterding, K.; Alonso-Diaz, D.; Waldmann, H. Angew. Chem., Int. Ed.
1998, 37, 688-749.
(30) Seelig, J. Q. ReV. Biophys. 1977, 10, 353-418.
(31) (a) Seelig, J.; Seelig, A. Q. ReV. Biophys. 1980, 13, 19-61. (b) Gro¨bner,
G.; Burnett, I. J.; Glaubitz, C.; Choi, G.; Mason, A. J.; Watts, A. Nature
2000, 405, 810-813. (c) Nevzorov, A. A.; Moltke, S.; Heyn, M. P.; Brown,
M. F. J. Am. Chem. Soc. 1999, 121, 7636-7643. (d) Nevzorov, A. A.;
Moltke, S.; Brown, M. F. J. Am. Chem. Soc. 1998, 120, 4798-4805.
(32) Brown, M. F. In Biological Membranes. A Molecular PerspectiVe from
Computation and Experiment; Merz, K. M., Roux, B., Eds.; Birkha¨user:
Boston, 1996; pp 175-252.
(10) Barbacid, M. Annu. ReV. Biochem. 1987, 56, 779-827.
(11) Murray, D.; Ben-Tal, N.; Honig, B.; McLaughlin, S. Structure 1997, 5,
985-989.
(12) Marshall, C. J. Science 1993, 259, 1865-1866.
(13) (a) Dudler, T.; Gelb, M. H. J. Biol. Chem. 1996, 271, 11541-11547. (b)
Dudler, T.; Gelb, M. H. Biochemistry 1997, 36, 12434-12441.
(14) Silvius, J. R. In Peptide-Lipid Interactions; Simon, S. A., McIntosh, T.
J., Eds. Elsevier: 2002; pp 371-395.
(33) Petrache, H. I.; Dodd, S. W.; Brown, M. F. Biophys. J. 2000, 79, 3172-
(15) Silvius, J. R.; l’Heureux, F. Biochemistry 1994, 33, 3014-3022.
(16) Shahinian, S.; Silvius, J. R. Biochemistry 1995, 34, 3813-3822.
(17) (a) Pool, C. T.; Thompson, T. E. Biochemistry 1998, 37, 10246-10255.
(b) Janosch, S.; Nicolini, C.; Ludolph, B.; Peters, C.; Vo¨lkert, M.; Hazlet,
T. L.; Gratton, E.; Waldmann, H.; Winter, R. J. Am. Chem. Soc. 2004,
126, 7496-7503.
3192.
(34) Nevzorov, A. A.; Trouard, T. P.; Brown, M. F. Phys. ReV. E. 1998, 58,
2259-2281.
(35) Trouard, T. P.; Alam, T. M.; Brown, M. F. J. Chem. Phys. 1994, 101,
5229-5261.
(36) Otten, D.; Brown, M. F.; Beyer, K. J. Phys. Chem. B 2000, 104, 12119-
(18) Peitzsch, R. M.; McLaughlin, S. Biochemistry 1993, 32, 10436-10443.
(19) Buser, C. A.; Sigal, C. T.; Resh, M. D.; McLaughlin, S. Biochemistry 1994,
33, 13093-13101.
(20) Schroeder, H.; Leventis, R.; Rex, S.; Schelhaas, M.; Nagele, E.; Waldmann,
H.; Silvius, J. R. Biochemistry 1997, 36, 13102-13109.
(21) Bader, B.; Kuhn, K.; Owen, D. J.; Waldmann, H.; Wittinghofer, A.;
Kuhlmann, J. Nature 2000, 403, 223-226.
12129.
(37) Brown, M. F.; Thurmond, R. L.; Dodd, S. W.; Otten, D.; Beyer, K. J. Am.
Chem. Soc. 2002, 124, 8471-8484.
(38) Brown, M. F.; Thurmond, R. L.; Dodd, S. W.; Otten, D.; Beyer, K. Phys.
ReV. E. 2001, 64, 010901.
(39) Martinez, G. V.; Dykstra, E. M.; Lope-Piedrafita, S.; Job, C.; Brown, M.
F. Phys. ReV. E. 2002, 66, 050902.
9
12264 J. AM. CHEM. SOC. VOL. 127, NO. 35, 2005